Riskpilot← Back to searchSign inGet full accessHALICARE ApS
APSActiveCVR 25502191Skodsborgparken 14, 3. thWholesale of other food · NACE 4638Est. 2000— employees
Revenue 2025
DKK 198K
EBITDA margin
100.0%
+54% vs 2024
Equity ratio
-35.3%
Financial strength
Net profit 2025
DKK 153K
+108% vs 2024
| Revenue | DKK 198K | — |
| EBITDA | DKK 198K | +54% |
| Net profit | DKK 153K | +108% |
| Total assets | DKK 722K | +53% |
| Equity | DKK -255K | +38% |
| Employees | — | — |
Legal name
HALICARE ApS
CVR number
25502191
Legal form
Anpartsselskab
NACE code
4638 · Wholesale of other food
Founded
12. juli 2000
Share capital
DKK 125.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er handels- og servicevirksomhed.
Address
Skodsborgparken 14, 3. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -250 | -58 | 16 | 60 | 82 | 137 | — | — | -214 | -63 | -81 | 302 | — | 198 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -119 | -58 | 16 | 60 | 82 | 137 | -59 | 38 | -214 | -63 | -81 | 302 | 128 | 198 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -119 | -58 | 16 | 60 | 82 | 137 | -59 | 38 | -214 | -63 | -81 | 302 | 128 | 198 |
| Net financials | -28 | -44 | -44 | -28 | -24 | -22 | -18 | -21 | -30 | -38 | -40 | -84 | -32 | 1 |
| Profit before tax | -147 | -101 | -28 | 32 | 58 | 115 | -78 | 16 | -243 | -101 | -121 | 218 | 96 | 199 |
| Tax | 66 | -16 | -8 | 11 | 16 | 27 | -14 | 6 | -50 | 58 | -25 | 49 | 22 | 46 |
| Net profit | -212 | -85 | -20 | 22 | 42 | 87 | -64 | 10 | -193 | -159 | -96 | 169 | 74 | 153 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 699 | 674 | 592 | 553 | 370 | 457 | 411 | 531 | 546 | 480 | 532 | 745 | 471 | 722 |
| Equity | -196 | -281 | -300 | -279 | -236 | -149 | -213 | -203 | -396 | -555 | -651 | -482 | -408 | -255 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 895 | 955 | 892 | 831 | 607 | 606 | 624 | 734 | 942 | 1.035 | 1.183 | 1.227 | 879 | 977 |
| Total debt | 895 | 955 | 892 | 831 | 607 | 606 | 624 | 734 | 942 | 1.035 | 1.183 | 1.227 | 879 | 977 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122025
Equity ratio
-35.3%
This company
38.2%
Market median
-192% vs market
20122025
Return on equity
15327700.0%
This company
18.4%
Market median
+83302617% vs market
20122025
Net profit margin
77.6%
This company
8.1%
Market median
+858% vs market
20122025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20122025
Debt / equity
3.83×
This company
0.62×
Market median
-518% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
Ri | Audit | 2000 | — | — |
EJ Management | Management | 2003 | — | — |
LJ Management | Management | 2000 | — | — |
MV Management | Management | 2000 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
EJP PHARMACEUTICAL ApS | Company | 100.0% | 100.0% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EJP PHARMACEUTICAL ApS
HALICARE ApS Board members of HALICARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Revisorerne i Sydsjælland | Audit | 0 companies |
| Ejvind Jersie Pedersen | Management | 0 companies |
| Lene Juul Nielsen | Management | 0 companies |
| Mette Vølund | Management | 0 companies |